When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Prostatite aguda

Ver PDF
  • Visão geral
  • Teoria
  • Diagnóstico
  • Tratamento
  • ACOMPANHAMENTO
  • Recursos
Última revisão: 21 Jan 2026
Última atualização: 17 Sep 2025

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presença de fatores de risco
  • febre, calafrios, mal-estar
  • próstata com sensibilidade à palpação
Detalhes completos

Outros fatores diagnósticos

  • idade <50 anos
  • polaciúria
  • disúria
  • diminuição do fluxo urinário
  • dor perineal
  • glândula esponjosa, quente ou amolecida
  • sonda vesical de demora
  • biópsia prostática transretal recente
  • cirurgia transuretral recente
Detalhes completos

Fatores de risco

  • infecção do trato urinário (ITU)
  • aumento prostático benigno
  • instrumentação/manipulação do trato urinário
  • saúde geral ruim/imunossupressão
  • tabagismo e consumo de bebidas alcoólicas
  • genética
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • urinálise
  • urocultura
  • hemoculturas
Detalhes completos

Investigações a serem consideradas

  • ultrassonografia transretal
  • teste de 2 frascos ou 4 frascos
  • citologia da urina
Detalhes completos

Treatment algorithm

ACUTE

sinais de sepse

sem sinais de sepse

Contributors

Authors

Altaf Mangera, MBChB (Hons), MD, FRCS (Urol)

Consultant Urologist

Department of Urology

Royal Hallamshire Hospital

Sheffield

UK

Disclosures

AM declares that he has no competing interests.

Acknowledgements

Altaf Mangera would like to gratefully acknowledge Christopher Chapple and Robyn Webber, previous contributors to this topic. CC is a consultant for Proverum, MUVON Therapeutics, and Pierre Fabre.

Peer reviewers

Hans Hedelin, MD

Department of Urology and Centre for Research and Development

Karnsjukhuset

Skovde

Sweden

Disclosures

HH declares that he has no competing interests.

Benjamin A. Lipsky, MD, FACP, FIDSA, FRCP

Professor of Medicine

University of Washington

VA Puget Sound Health Care System

Seattle

WA

Disclosures

BAL has received research funding from, and been a consultant to, several pharmaceutical companies that make antibiotic agents that might be used for treating bacterial prostatitis.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Rothman JR, Jaffe WI. Prostatitis: updates on diagnostic evaluation. Curr Urol Rep. 2007 Jul;8(4):301-6. Abstract

European Association of Urology. Guidelines on urological infections. Mar 2025 [internet publication].Full text

Nickel JC. Prostatitis. Can Urol Assoc J. 2011 Oct;5(5):306-15.Full text  Abstract

National Institute for Health and Care Excellence. Prostatitis (acute): antimicrobial prescribing. Oct 2018 [internet publication].Full text

Reference articles

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

  • Differentials

    • Hiperplasia prostática benigna (HPB)
    • Câncer de próstata
    • Infecção do trato urinário (ITU)
    More Differentials

  • Guidelines

    • Urological infections
    • AAUS guideline for acute bacterial prostatitis 2021
    More Guidelines

  • Patient information

    Prostatite

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer